Across TCGA pan-cancer cohorts, ZNF734P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated ZNF734P data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher ZNF734P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF734P expression acts as an unfavorable survival marker, although some lineages such as LIHC and SKCM show a favorable association.
KIRP, STAD, and THCA are the cancer types where ZNF734P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.